Reidsville, North Carolina Clinical Trials

A listing of Reidsville, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis

HiLo will be a pragmatic, open-label, multicenter, cluster-randomized trial of ~4400 patients with ESRD undergoing in-center maintenance hemodialysis at 120-150 units maintained by two dialysis organizations that care for a substantial proportion of the US dialysis population. The 1st objective of HiLo is to test the following primary and secondary …

DaVita Reidsville Dialysis
 (0.8 away) Contact site
  • 0 views
  • 30 May, 2021
  • +30 other locations
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

This randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer. Drugs used in chemotherapy, such as doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, …

breast conserving surgery
lumpectomy
primary tumor
triple-negative breast cancer
ductal carcinoma in situ
Cone Health Cancer Center
 (21.1 away) Contact site
  • 814 views
  • 24 Jan, 2021
  • +810 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

tumor cells
adenocarcinoma
lung cancer
gemcitabine
metastasis
Danville Regional Medical Center
 (20.3 away) Contact site
  • 1103 views
  • 04 Aug, 2021
  • +1138 other locations
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

This randomized phase III trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast cancer previously treated with chemotherapy and surgery. Lymph node dissection may remove cancer cells that have spread to nearby lymph nodes in …

lumpectomy
ductal carcinoma in situ
estrogen
pertuzumab
her-2
Cone Health Cancer Center
 (21.1 away) Contact site
  • 476 views
  • 22 Jun, 2021
  • +741 other locations
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will …

Cone Health Cancer Center
 (21.1 away) Contact site
  • 193 views
  • 10 May, 2021
  • +876 other locations
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important …

mitomycin
congestive heart failure
ct scan
tumor cells
biomarker analysis
Cone Health Cancer Center
 (21.1 away) Contact site
  • 387 views
  • 25 Jan, 2021
  • +1092 other locations
Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

This phase II Lung-MAP trial studies how well rucaparib works in treating patients with genomic loss of heterozygosity (LOH) high and/or deleterious BRCA1/2 mutation stage IV non-small cell lung cancer or that has come back. Rucaparib may stop the growth of tumor cells by blocking some of the enzymes needed …

insulin
recurrent non-small cell lung cancer
ct scan
systemic chemotherapy
lung cancer
Cone Health Cancer Center
 (21.1 away) Contact site
  • 175 views
  • 09 May, 2021
  • +746 other locations
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian Fallopian Tube or Primary Peritoneal Cancer

This phase II/III trial studies how well pegylated liposomal doxorubicin hydrochloride with atezolizumab and/or bevacizumab work in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has come back (recurrent). Chemotherapy drugs, such as pegylated liposomal doxorubicin hydrochloride, work in different ways to stop the growth of tumor …

primary peritoneal carcinoma
monoclonal antibodies
tumor cells
adenocarcinoma
ovarian cancer
Annie Penn Memorial Hospital
 (0.8 away) Contact site
  • 185 views
  • 04 Aug, 2021
  • +748 other locations
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502

This phase III trial evaluates mammographic breast density in participants with hormone receptor-negative breast cancer enrolled on study A011502. High breast density has been shown to be a strong risk factor for developing breast cancer and decreasing breast density may decrease the risk for breast cancer. Participants treated with aspirin …

cancer
tamoxifen
aromatase inhibitor
endocrine therapy
breast imaging reporting and data system
Cone Health Cancer Center
 (21.1 away) Contact site
  • 2784 views
  • 26 Jul, 2021
  • +550 other locations